Myelodysplasia occurring after fludarabine treatment for chronic lymphocytic leukaemia
- PMID: 9218157
- DOI: 10.1046/j.1365-2257.1997.00229.x
Myelodysplasia occurring after fludarabine treatment for chronic lymphocytic leukaemia
Abstract
The purine analogue, fludarabine, is of proven efficacy in the treatment of lymphoid malignancies. The drug appears to be well tolerated with minimal side-effects, and few toxicities have been observed. A case of myelodysplasia occurring after therapy with fludarabine is presented and its implications are discussed.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
